Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer


The lifetime risk of breast cancer may approach 80–90% in women who have germline mutations of either of two genes, BRCA1 or BRCA2 (refs. 1–3). A single BRCA1 mutation, 185delAG, has been noted in approximately 20% of Ashkenazi Jewish women with early onset breast cancer and in 0.9% of the Ashkenazi population4–6. We recently detected a 6174delT frameshift mutation in BRCA2 in an hereditary breast cancer kindred of Ashkenazi Jewish ancestry. Here, we investigated the frequency of this mutation in 200 women with early-onset breast cancer. Six of 80 Ashkenazi Jewish women (8%) diagnosed with breast cancer before the age of 42, were heterozygous for the 6174delT mutation, compared to none of 93 non-Jewish women diagnosed with breast cancer at the same age (P = .005). These cases were ascertained without regard to family history. Two of 27 (7%) additional Jewish families in which the proband was diagnosed with breast cancer at age 42 to 50 and had a family history of breast or ovarian cancer had germline 6174delT mutations. The results of this report suggest that a recurrent mutation of BRCA1 and a recurrent mutation of BRCA2 together may account for over a quarter of all early-onset breast cancer cases and two thirds of early-onset breast cancer in the setting of a personal or family history of ovarian cancer in Ashkenazi Jewish women.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Easton, D. et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52, 678–701 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. 2

    Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265, 2088–2090 (1994).

    CAS  Article  Google Scholar 

  3. 3

    Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).

    CAS  Article  Google Scholar 

  4. 4

    Struewing, J.P. et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet. 11, 198–200 (1995).

    CAS  Article  Google Scholar 

  5. 5

    FitzGerald, M.G. et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med. 334, 143–149 (1996).

    CAS  Article  Google Scholar 

  6. 6

    Offit, K. et al. Germline BRCA1 185delAG mutations in Jewish women affected by breast cancer. Lancet (in the press).

  7. 7

    Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792 (1995).

    CAS  Article  Google Scholar 

  8. 8

    Tavtigian, S.V. et al. The BRCA2 gene and mutations in 13q-linked kindreds. Nature Genet. 12, 333–337 (1996).

    CAS  Article  Google Scholar 

  9. 9

    Langston, A.A. et al. BRCA1 mutations in a population-based sample of young women with early-onset breast cancer. N. Engl. J. Med. 334, 137–142 (1996).

    CAS  Article  Google Scholar 

  10. 10

    Offit, K. & Brown, K. Quantitative risk counseling for familial cancer: a resource for clinical oncologists. J. Clin. Oncol. 12, 1724–1736 (1994).

    CAS  Article  Google Scholar 

  11. 11

    Saiki, R.K. et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230, 1350–1354 (1985).

    CAS  Article  Google Scholar 

  12. 12

    Mullis, K. et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol. 51, 263–273 (1986).

    CAS  Article  Google Scholar 

  13. 13

    Weber, J.L. & May, P.E. Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am. J. Hum. Genet. 44, 388–96 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Neuhausen, S., Gilewski, T., Norton, L. et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13, 126–128 (1996).

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing